Advanced search
Add to list

Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study

(2006) BRITISH JOURNAL OF CANCER. 94(4). p.481-485
Author
Organization

Citation

Please use this url to cite or link to this publication:

MLA
DEMOLS, A., et al. “Gemcitabine and Oxaliplatin (GEMOX) in Gemcitabine Refractory Advanced Pancreatic Adenocarcinoma: A Phase II Study.” BRITISH JOURNAL OF CANCER, vol. 94, no. 4, NATURE PUBLISHING GROUP, 2006, pp. 481–85.
APA
DEMOLS, A., Peeters, M., POLUS, M., MARECHAL, R., GAY, F., MONSAERT, E., … VAN LAETHEM, J. (2006). Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study. BRITISH JOURNAL OF CANCER, 94(4), 481–485.
Chicago author-date
DEMOLS, A, Marc Peeters, M POLUS, R MARECHAL, F GAY, ELS MONSAERT, A HENDLISZ, and JL VAN LAETHEM. 2006. “Gemcitabine and Oxaliplatin (GEMOX) in Gemcitabine Refractory Advanced Pancreatic Adenocarcinoma: A Phase II Study.” BRITISH JOURNAL OF CANCER 94 (4): 481–85.
Chicago author-date (all authors)
DEMOLS, A, Marc Peeters, M POLUS, R MARECHAL, F GAY, ELS MONSAERT, A HENDLISZ, and JL VAN LAETHEM. 2006. “Gemcitabine and Oxaliplatin (GEMOX) in Gemcitabine Refractory Advanced Pancreatic Adenocarcinoma: A Phase II Study.” BRITISH JOURNAL OF CANCER 94 (4): 481–485.
Vancouver
1.
DEMOLS A, Peeters M, POLUS M, MARECHAL R, GAY F, MONSAERT E, et al. Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study. BRITISH JOURNAL OF CANCER. 2006;94(4):481–5.
IEEE
[1]
A. DEMOLS et al., “Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study,” BRITISH JOURNAL OF CANCER, vol. 94, no. 4, pp. 481–485, 2006.
@article{332016,
  author       = {{DEMOLS, A and Peeters, Marc and POLUS, M and MARECHAL, R and GAY, F and MONSAERT, ELS and HENDLISZ, A and VAN LAETHEM, JL}},
  issn         = {{0007-0920}},
  journal      = {{BRITISH JOURNAL OF CANCER}},
  language     = {{eng}},
  number       = {{4}},
  pages        = {{481--485}},
  publisher    = {{NATURE PUBLISHING GROUP}},
  title        = {{Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study}},
  volume       = {{94}},
  year         = {{2006}},
}

Web of Science
Times cited: